DR. LAL PATHLABS LIMITED

Analyst Reco. Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Delayed NSE India S.E. Other stock markets 02:27:29 2025-07-09 am EDT			5-day change	1st Jan Change
2,945.10 ^INR	+2.26%		+6.11%	-1.90%

Jun. 25	Dr. Lal PathLabs Expands Genomics Capabilities with New Sequencing System	MT
Apr. 28	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,560 From INR3,315, Keeps at Buy	MT

Analyst Reco.

Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,560 From INR3,315, Keeps at Buy	Apr. 28	MT
Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR3,315 From INR3,310	Jan. 31	MT
Nomura Downgrades Dr. Lal PathLabs to Neutral From Buy, Adjusts Price Target to INR3,310 From INR3,720	24-10-25	MT
Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,720 From INR2,713, Keeps at Buy	24-08-12	MT
Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505	24-05-14	MT
Nomura Adjusts Dr. Lal Pathlabs’ Price Target to INR2,505 From INR2,465, Keeps at Neutral	24-02-05	MT
Nomura Upgrades Dr. Lal Pathlabs to Neutral From Reduce, Adjusts Price Target to INR2,465 From INR,2002	23-11-06	MT
Nomura Downgrades Dr. Lal Pathlabs to Reduce From Neutral, Adjusts Price Target to INR2,002 From INR1,835	23-07-31	MT
Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,835 From INR1,864, Keeps at Neutral	23-05-15	MT
Nomura Upgrades Dr. Lal PathLabs to Neutral From Reduce, Adjusts Price Target to INR1,864 From INR1,819	23-02-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

All our actual portfolios continue to outperform their benchmark.

Discover our performance

Discover our performance